A phase I/II study to assess the effect of soluble beta-1,3/1,6-glucan in combination with standard therapy in patients with breast cancer

Femme Homme

| Pays :
| Organes :
| Spécialités :

Extrait

Define the clinical toxicity and assess the biologic effects of oral SBG when given to breast cancer patients undergoing standard chemo- and antibody treatment

Critère d'inclusion

Breast Cancer

Liens

euctr
ictrp